No abstract available
Keywords:
Chronic myeloid leukaemia; Erythrocytosis; JAK-2; Polyglobulia; bcr-abl.
MeSH terms
-
Aged
-
Antineoplastic Agents / therapeutic use
-
Fusion Proteins, bcr-abl / genetics
-
Humans
-
Imatinib Mesylate / therapeutic use
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
-
Male
-
Mutation
-
Polycythemia / complications*
Substances
-
Antineoplastic Agents
-
Imatinib Mesylate
-
Fusion Proteins, bcr-abl